Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Metastatic Castration Resistant Prostate Cancer × rucaparib × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Fallopian Tube Neoplasms 5 Ovarian Neoplasms 4 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Metastatic Castration Resistant Prostate Cancer 1 Genital Neoplasms, Male 1 Adenocarcinoma, Clear Cell 1

Interventions

Abiraterone Acetate 2 rucaparib 1 enzalutamide 1 Prednisone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02975934 2025-07-25

TRITON3

pharmaand GmbH

Phase 3 Completed

405 enrolled 34 charts 3 FDA

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡